Assessment of risk factors associated with diabetes
Assessment of risk factors associated with diabetes
DOI:
https://doi.org/10.52461/ijnms.v1i2.836Keywords:
Key words: Cardiovascular Disease, Diabetes Mellitus, Fasting Blood Sugar, Hepatitis C Virus, Hypertension, Insulin Dependent Diabetes Mellitus, Wealth Health Organization,Abstract
Abstract:
Objective: Purpose of the study was to assess to risk factors of diabetes type II and complications in diabetic patient of tertiary care hospital. Methods/Design: Cross sectional study conducted to evaluate the risk factors associated with diabetes Mellitus. Setting: Tertiary hospitals of Islamabad and Azad Kashmir was selected for the current study. Participants: 50 patients assessed without any gender discrimination age between 35 to 85 years for risk factors and complications. Intervention: Data was collected from patients that were bed ridden admitted in hospitals. A total of 50 patients were included in this study with age limit more than 35 years and without any discrimination of gender. Primary Outcome Measures: In tertiary care hospitalized patient’s obesity, inactivity and family history were the major risk factor for diabetes mellitus type 2 and we calculated the obesity, inactivity and family history percentage in diabetic patients 63%, 49% and 67% respectively. Results: Percentage of risk factors calculated the obesity, inactivity and family history in diabetic patients 63%, 49% and 67% respectively. Macro vascular complications in patients with diabetes mellitus type 2 were stroke 3%, angina 8%, hypertension and cognitive impairment have highest percentages i.e., 78%. 46% patients were suffering from ulceration; gangrene and amputation have percentages 19% and 3% respectively. Patients with microvascular complications of diabetic nephropathy were assessed for their albuminuria 25%, edema 32% and incontinence 28%. Conclusion: These complications can be avoided if patients of DM type 2 adopt a healthy lifestyle, do exercise and monitor their blood glucose levels regularly. Patients should also control their blood pressure to avoid damage to their microvasculature.
References
1. WHO, definition of diabetes mellitus
2 .Lippincott’s, Pharmacology. Insulin and other glucose lowering drugs; Page No: 301,302
3.Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183–1197
4.Wells, K., 1995. Concise Pathology. By Parakrama Chandrasoma and Clive R. Taylor. Plastic and Reconstructive Surgery, 96: 1227-1227.
5.Kim C,Newton KM, KnoppRH.Gastational diabetes and the incidence of type 2 diabetes, Asystemic review. Diabetes care 2002; (25): 1862-1868
6.T.E. Friedemann, B.B. Sheft and V.C. Miller, “An assessment of the value of nitroprusside reaction for the determination of ketone bodies in urine” Queens Bullettin of Northwestern University Medical School, (20): 301-310, 1946.
7.WHO ranks Pakistan 7th on diabetes prevalence list (Nation.com) The Nation, WHO ranks Pakistan 7th on diabetes prevalence list International Diabetic Federation Diabetes [online] 2006 [cited 2010 July 18].
8.Seminar on “Diabetes in Asia” (Ambady Ramachandran, Ronaldo Ching, Wan Ma, Chamukuttan Snehalatha)
9.“Highly prevalence of diabetes and Impaired glucose tolerance in India. National Urban Diabetes”.
10.Ramachandran, C.Snehalatha, A. Kapur, V.Vijay, V.Mohan, A.K.Das , P.V Rao, C.S Yajnik, K.M Prasnna Kumar, Jyotsna D. Nair For The Concise Pathology By Parakrama Chandrasoma And Clive R. Taylor.
11.Walker, R., C. Edwards, and C. Edwards, Clinical pharmacy and therapeutics. 2003: Churchill Livingstone Edinburg.
12.Fletcher, B., M. Gulanick, and C. Lamendola, Risk factors for type 2 diabetes mellitus. Journal of Cardiovascular Nursing, 2002. 16(2): p. 17-23.
13.Ahmed, U., Prevalence of chronic complications and associated factors in type 2 diabetes. J Pak Med Assoc, 2004. 54: p. 54-59.
14.Ramachandran, C.Snehalatha, A. KAPUR, V.VIJAY, V.MOHAN, A.K.DAS , P.V RAO, C.S YAJNIK, K.M PRASNNA KUMAR, JYOTSNA D. NAIR for the Concise pathology by PARAKRAMA CHANDRASOMA and CLIVE R. TAYLOR
15.Yen, V., Microvascular Complications of Diabetes Mellitus, in Principles of Diabetes Mellitus. 2004, Springer. p. 317-328.
16.Gross, J.L., et al., Diabetic Nephropathy: Diagnosis, Prevention, and Treatment. Diabetes Care, 2005.28(1): p. 164-176.
17.Duby, J.J., et al., Diabetic Neuropathy: An intensive review. American Journal of Health-System Pharmacy, 2004.61(2): p. 160-173.
18.Walker, R., C. Edwards, and C. Edwards, Clinical pharmacy and therapeutics. 2003: Churchill Livingstone Edinburg.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 International Journal of Natural Medicine and Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
You are free to:
• Share: copy and redistribute the material in any medium or format.
• Adapt: remix, transform, and build upon the material.
• Attribution: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
• NonCommercial: You may not use the material for commercial purposes.
• No additional restrictions: You may not apply legal terms or technological measures, that legally restrict others from doing anything the license permits.